首页 › 肺癌 › 佛罗里达州 › Fort Lauderdale
Fort Lauderdale FL 肺癌临床试验
7项针对 肺癌的研究正在 Fort Lauderdale及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
招募中3 期
- Holy Cross Hospital, Fort Lauderdale
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- Holy Cross Hospital, Fort Lauderdale
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
招募中3 期
- Holy Cross Hospital, Fort Lauderdale
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- Holy Cross Hospital, Fort Lauderdale
- Broward Health Medical Center, Fort Lauderdale
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
招募中3 期
- Helios Clinical Research, Fort Lauderdale
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
招募中2/3 期
- Helios Clinical Research - Fort Lauderdale, Fort Lauderdale
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
招募中1/2 期
- Holy Cross Hospital (site 213), Fort Lauderdale
其他城市的 肺癌试验
- Houston, TX78 项研究
- Boston, MA62 项研究
- New York City, NY60 项研究
- Los Angeles, CA45 项研究
- Arlington, VA41 项研究
- Washington, DC41 项研究
- Chicago, IL41 项研究
- Baltimore, MD40 项研究
- Nashville, TN40 项研究
- St. Louis, MO39 项研究
- Columbus, OH37 项研究
- Philadelphia, PA36 项研究
Fort Lauderdale的其他研究
- 非小细胞肺癌12 项研究
- 癌症（所有类型）7 项研究
- 心力衰竭6 项研究
- 黄斑变性5 项研究
- 卵巢癌4 项研究
- 乳腺癌4 项研究
- 多发性骨髓瘤3 项研究
- 血液癌症3 项研究
- 慢性肾病3 项研究
- 心血管疾病3 项研究
- 结肠癌3 项研究
- 结直肠癌3 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。